[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

McAvey et al., 2011 - Google Patents

How many eggs are needed to produce an assisted reproductive technology baby: is more always better?

McAvey et al., 2011

View HTML
Document ID
5333975377078837813
Author
McAvey B
Zapantis A
Jindal S
Lieman H
Polotsky A
Publication year
Publication venue
Fertility and sterility

External Links

Snippet

OBJECTIVE: To evaluate the association between the number of mature (metaphase II [MII]) oocytes per assisted reproductive technology (ART) cycle and the likelihood of live birth. DESIGN: Retrospective study. SETTING: Academic infertility practice. PATIENT (S): Seven …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0012—Ovulation-period determination
    • A61B2010/0016—Ovulation-period determination based on measurement of electric currents, e.g. conductivity tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application

Similar Documents

Publication Publication Date Title
McAvey et al. How many eggs are needed to produce an assisted reproductive technology baby: is more always better?
Jing et al. Increased pregnancy complications following frozen-thawed embryo transfer during an artificial cycle
Zhao et al. The effect of endometrial thickness and pattern measured by ultrasonography on pregnancy outcomes during IVF-ET cycles
Kofinas et al. Serum progesterone levels greater than 20 ng/dl on day of embryo transfer are associated with lower live birth and higher pregnancy loss rates
Lahoud et al. Elevated progesterone in GnRH agonist down regulated in vitro fertilisation (IVFICSI) cycles reduces live birth rates but not embryo quality
Hourvitz et al. In vitro maturation for patients with repeated in vitro fertilization failure due to “oocyte maturation abnormalities”
Shakerian et al. Endometrial thickness is not predictive for live birth after embryo transfer, even without a cutoff
Williams et al. Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist
Özçakir et al. Premature luteinization defined as progesterone estradiol ratio> 1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin‐releasing hormone agonist cycles
Agha-Hosseini et al. Natural cycle versus artificial cycle in frozen-thawed embryo transfer: a randomized prospective trial
JP7157108B2 (en) How to treat infertility
Bartels et al. The window is wide: flexible timing for vitrified–warmed embryo transfer in natural cycles
Griesinger et al. No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH
Weiss et al. Ectopic pregnancy risk factors for ART patients undergoing the GnRH antagonist protocol: a retrospective study
Keane et al. Higher β-HCG concentrations and higher birthweights ensue from single vitrified embryo transfers
Connell et al. Larger oocyte cohorts maximize fresh IVF cycle birth rates and availability of surplus high-quality blastocysts for cryopreservation
Benmachiche et al. Impact of mid-luteal phase GnRH agonist administration on reproductive outcomes in GnRH agonist-triggered cycles: a randomized controlled trial
Groenewoud et al. Spontaneous LH surges prior to HCG administration in unstimulated-cycle frozen–thawed embryo transfer do not influence pregnancy rates
Christianson et al. Innovations in assisted reproductive technologies: impact on contemporary donor egg practice and future advances
Ozgur et al. Agonist depot versus OCP programming of frozen embryo transfer: a retrospective analysis of freeze-all cycles
Mendoza-Tesarik et al. GnRH agonist treatment of luteal phase deficiency in HCG-triggered IVF cycles: A matched case-control study
Su et al. Age is a major prognosticator in extremely low oocyte retrieval cycles
Pereira et al. Effect of methotrexate or salpingectomy for ectopic pregnancy on subsequent in vitro fertilization–embryo transfer outcomes
Braam et al. In vitro maturation of oocytes in women at risk of ovarian hyperstimulation syndrome-a prospective multicenter cohort study
Duran et al. Impact of male age on the outcome of assisted reproductive technology cycles using donor oocytes